AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development

April 28, 2020

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, includes existing investors Broadview Ventures and aMoon Fund as well as new investors Hatteras Venture Partners, Catalyst Health Ventures (CHV) and Longview Ven-tures, a Broadview affiliate. The investment supports efforts to reach US and EU regula-tory clearances for AtaCor’s novel extracardiac temporary pacing system as well as development efforts for additional extracardiac therapies.

Read full press release here.